Total Funding
2
6
Total FundingPrivate Equity raised
Growth Score 2 in past quarter
-5 pts
Heat Score 6 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
399997
Acetylon Pharmaceuticals manufactures small molecule drugs to realize the therapeutic potential of histone deacetylase.
Jay Bradner: Co-FounderPast Role: Harvard Medical School, Associate Professor- Kenneth Anderson: Co-Founder
About the Company
Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company was incorporated in 2008 and is based in Boston, Massachusetts.



